- Contract Packaging
- Leaders in Packaging
Article | September 30, 1997
FDA announced it plans to require warnings on labels of the popular prescription diet drug "fen/phen" after receiving reports that the drug combination can cause serious damage to heart valves.
Fen/phen is a combination of fenfluramine and phentermine both of which are approved for short-term use though not specifically in combination. Studies are planned of fen/phen users as well as for several other chemically similar prescription drugs used in dieting.
Related Sponsored Content
E-BOOK SPECIAL REPORT
44 Best Package Designs
Sign up to receive timely updates from our editors and download this e-book of our editors’ selections for most innovative package designs of the past year.